51. Scleroderma Clinical trials / Disease details

Clinical trials : 523 / Drugs : 608 - (DrugBank : 156) / Drug target genes : 114 - Drug target pathways : 215

4 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02866552 (ClinicalTrials.gov)	January 2017	5/8/2016	SCLERoderma et Adipose-DErived Stroma Cells		Systemic Sclerosis	Drug: Stromal Vascular fraction;Drug: Ringer lactate	Assistance Publique Hopitaux De Marseille	NULL	Not yet recruiting	18 Years	N/A	Both	44	Phase 2	France
2	NCT02975960 (ClinicalTrials.gov)	October 25, 2016	9/11/2016	ADMSCs for the Treatment of Systemic Sclerosis	Adipose Tissue-derived Mesenchymal Stem Cells for Cell-based Therapy in the Treatment of Systemic Sclerosis	Systemic Sclerosis	Biological: injection of autologous stromal vascular fraction	The Catholic University of Korea	Seoul St. Mary's Hospital	Completed	18 Years	N/A	All	7	N/A	Korea, Republic of
3	NCT02558543 (ClinicalTrials.gov)	September 2015	31/8/2015	Subcutaneous Injection of Autologous Adipose Tissue-derived Stromal Vascular Fraction Into the Fingers of Patients With Systemic Sclerosis	Subcutaneous Injection of Autologous Adipose Tissue-derived Stromal Vascular Fraction Into the Fingers of Patients With Systemic Sclerosis : Controlled Clinical Trial With Efficacy Assessment	Scleroderma, Systemic	Drug: Stromal Vascular fraction;Drug: Ringer lactate	Assistance Publique Hopitaux De Marseille	NULL	Terminated	18 Years	N/A	All	40	Phase 2	France
4	NCT04387825 (ClinicalTrials.gov)	August 13, 2015	10/5/2020	Safety Of Fat Micrografts With Adipose-Derived Stromal Vascular Fraction In Hands Of Patients With Systemic Sclerosis	Lipograft Safety Enriched With Vascular Stromal Fraction Derived From Adipose Tissue, to Treatment of Digital Joint Fibrosis and Refractory Ischemic Digital Ulcers Caused by Systemic Sclerosis	Systemic Sclerosis	Drug: ADSVF application in the right hand	Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran	National Council of Science and Technology, Mexico	Completed	18 Years	N/A	All	20	Phase 2	Mexico